Maintaining cancer care in the face of COVID-19April 1, 2020COVID-19 UpdatesPatient & Survivor CareCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Cancer care and COVID-19 in Seattle, the first U.S. epicenterMarch 23, 2020COVID-19 UpdatesCNS/Brain CancerBreast CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
How is oncology adapting to COVID-19?March 23, 2020COVID-19 UpdatesBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Disruptions in cancer care in the era of COVID-19March 20, 2020COVID-19 UpdatesPatient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic Cancer
Largest meeting on cancer research canceled: AACRMarch 11, 2020Mixed TopicsLung CancerHead & Neck/Thyroid CancersGynecologic CancerGenitourinary CancerGastroenterologyCNS/Brain Cancer
CLTX-CAR T cells exhibit preclinical activity and move on to a clinical trialMarch 4, 2020CNS/Brain Cancer
Late effects in young cancer survivors underscore importance of high-risk screeningFebruary 21, 2020Mixed TopicsLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersSarcoma & GISTRenal Cell CarcinomaCNS/Brain CancerGenitourinary Cancer
FDA: Cell phones still look safeFebruary 11, 2020Mixed TopicsCNS/Brain CancerBreast CancerLung CancerLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationGynecologic Cancer
Data emerging to support personalized nutrition in oncologyFebruary 8, 2020Breast CancerCNS/Brain CancerPreventive Care
Global project reveals cancer’s genomic playbookFebruary 5, 2020Mixed TopicsCNS/Brain CancerBreast CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHead & Neck/Thyroid CancersGynecologic Cancer
QoL good for MGMT-methylated glioblastoma patients with lomustine-temozolideJanuary 2, 2020CNS/Brain CancerNeuro-oncologyPatient & Survivor Care
